These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18457615)

  • 1. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons.
    Muscal E; Brey RL
    Curr Rheumatol Rep; 2008 Jan; 10(1):67-73. PubMed ID: 18457615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome and the brain in pediatric and adult patients.
    Muscal E; Brey RL
    Lupus; 2010 Apr; 19(4):406-11. PubMed ID: 20353978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine.
    Muscal E; Brey RL
    Int J Clin Pract; 2007 Sep; 61(9):1561-8. PubMed ID: 17596187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment.
    Islam MA; Alam F; Sasongko TH; Gan SH
    Curr Pharm Des; 2016; 22(28):4451-69. PubMed ID: 27229722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis].
    Zawilska K
    Pol Arch Med Wewn; 2007; 117 Suppl():41-5. PubMed ID: 18778019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards evidence-based treatment of thrombotic antiphospholipid syndrome.
    Derksen RH; de Groot PG
    Lupus; 2010 Apr; 19(4):470-4. PubMed ID: 20353990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment].
    van Mens TE; Middeldorp S; Coppens M
    Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin.
    Markousis-Mavrogenis G; Sfikakis PP; Mavrogeni SI; Tektonidou MG
    Clin Rheumatol; 2021 Jul; 40(7):2559-2568. PubMed ID: 33196982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
    Fischer-Betz R; Specker C; Brinks R; Schneider M
    Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid syndrome--interdisciplinary problem].
    Wiszniewska M; Wiszniewski P; Hanszke E; Gaik I; Turowiecka Z
    Pol Arch Med Wewn; 2006 May; 115(5):443-6. PubMed ID: 17195358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.
    Madison JA; Gockman K; Hoy C; Tambralli A; Zuo Y; Knight JS
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):17. PubMed ID: 35197077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
    Sayar Z; Burke S; Mittal P; Cohen H
    Lupus; 2022 Oct; 31(12):1485-1490. PubMed ID: 36074077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurological aspects in antiphospholipid syndrome].
    Kitagawa Y
    Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered.
    Islam MA; Alam F; Kamal MA; Wong KK; Sasongko TH; Gan SH
    CNS Neurol Disord Drug Targets; 2016; 15(10):1253-1265. PubMed ID: 27658514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.